Showing results (1281-1290 of 4,634) with videos related to
Sort By:
Pageof 464
Anti-Cancer Drugs|August 1, 1995
Stability of ifosfamide in solutions for multiday infusion by external pumpL Leone, A Comandone, C Oliva, et al.Anti-Cancer Drugs|June 1, 1995
Polymerase chain reaction analysis of cisplatin-induced mitochondrial DNA damage in human ovarian carcinoma cellsS S Daoud, M K Clements, C L SmallAnti-Cancer Drugs|June 1, 1995
Growth inhibition of human tumor xenografts in nude mice by treatment with the antitumor agent 4,6-benzylidene-d1-D-glucose (P-1013)C B Dunsaed, J M Dornish, T E Aastveit, et al.Anti-Cancer Drugs|June 1, 1995
The effect of 5-fluorouracil on cisplatin induced DNA interstrand cross-linking in a mouse ascites tumor growing in vivoF Lewin, U Ringborg, S Skog, et al.Anti-Cancer Drugs|December 1, 1993
Gastrin antagonists in the treatment of gastric cancerS A Watson, R J SteeleAnti-Cancer Drugs|April 1, 1993
Can hematopoietic growth factors be used to improve the success of cytotoxic chemotherapy?M BronchudAnti-Cancer Drugs|April 1, 1993
Cisplatin and carboplatin induced changes in the neurohypophysis and parathyroid, and their role in nephrotoxicityS K Aggarwal, J M FadoolAnti-Cancer Drugs|April 1, 1993
A phase I trial of trimetrexate (NSC352122) on a daily x 5 schedule in patients with refractory adult leukemiaG Rodriguez, T D Brown, F M Balis, et al.Anti-Cancer Drugs|April 1, 1993
Antitumor activity of a new series of platinum complexes: trans(+/-)-1,2-cyclohexanediammineplatinum(II) conjugated to acid polysaccharidesM Maeda, N Takasuka, T Suga, et al.Anti-Cancer Drugs|April 1, 1993
Inhibition of c-myc in breast and ovarian carcinoma cells by 1,25-dihydroxyvitamin D3, retinoic acid and dexamethasoneD E Saunders, C Christensen, N L Wappler, et al.Pageof 464